Finally, much more is needed to correlate GalNAcT3 and GalNAcT6 expression with their capacity to aberrantly O-glycosylate the Muc1, and how this could affect the morphology, invasiveness and migration properties of RCC [41, 42]. The gene discussed is GALNT3; the disease is renal cell carcinoma.